54 / 62
C o n t e n i d o d i s p o n i b l e e n h t t p : / / www. n e umo l o g i a - p e d i a t r i c a . cl
52
Neumol Pediatr 2016; 11 (1): 49 - 52
Índice de aclaramiento pulmonar en pediatría
REFERENCIAS
1.
Robinson PD, Goldman MD, Gustafsson PM. Inert gas
washout: theoretical background and clinical utility in
respiratory disease. Respiration 2009;78:339-55
2.
Fuchs SI, Gappa M. Lung clearance index: clinical and
research applications in children. Paediatr Respir Rev
2011;12: 264-70
3.
Gustafsson PM. Inert gas washout in preschool children.
Paediatr Respir Rev 2005;6:239-45
4.
Robinson PD, Latzin P, Verbanck S, Hall GL, Horsley A,
Gappa M et al. Consensus statement for inert gas washout
measurement using multiple- and single- breath tests. Eur
Respir J 2013;41:507-22
5.
Kent L, Reix P, Innes JA, Zielen S, Le Bourgeois M, Braggion
C, et al. Lung clearance index: evidence for use in clinical
trials in cystic fibrosis. J Cyst Fibros 2014;13:123-38
6.
Aurora P, Bush A, Gustafsson P, Oliver C, Wallis C, Price J
et al. Multiple-breath washout as a marker of lung disease
in preschool children with cystic fibrosis. Am J Respir Crit
Care Med 2005;171:249-56
7.
Gustafsson PM, Aurora P, Lindblad A. Evaluation of
ventilation maldistribution as an early indicator of lung
disease in children with cystic fibrosis. Eur Respir J
2003;22:972-9
8.
Lum S, Gustafsson P, Ljungberg H, Hulskamp G, Bush A,
Carr SB, et al. Early detection of cystic fibrosis lung disease:
multiple-breath washout versus raised volume tests. Thorax
2007;62:341-7
9.
Stahl M, Joachim C, Blessing K, Hammerling S, Sommerburg
O, Latzin P et al. Multiple breath washout is feasible in
the clinical setting and detects abnormal lung function in
infants and young children with cystic fibrosis. Respiration
2014;87:357-63
10. Fuchs SI, Ellemunter H, Eder J, Mellies U, Grosse-Onnebrink
J, Tummler B et al. Feasibility and variability of measuring
the Lung Clearance Index in a multi-center setting. Pediatr
Pulmonol 2012;47:649-57
11. Owens CM, Aurora P, Stanojevic S, Bush A, Wade A, Oliver C,
et al. Lung Clearance Index and HRCT are complementary
markers of lung abnormalities in young children with CF.
Thorax 2011;66:481-8
12. Foundation CF. Cystic Fibrosis Foundation Patient Registry.
2012 annual report.
13. Australia CF. Cystic Fibrosis in australia 2012. 2012 annual
report.
14. Canada CF. The Canadian Cystic Fibrosis Registry. 2012
annual report.
15. Fuchs SI, Gappa M, Eder J, Unsinn KM, Steinkamp G,
Ellemunter H. Tracking Lung Clearance Index and chest CT
in mild cystic fibrosis lung disease over a period of three
years. Respir Med 2014;108:865-74
16. Gustafsson PM, De Jong PA, Tiddens HA, Lindblad
A. Multiple-breath inert gas washout and spirometry
versus structural lung disease in cystic fibrosis. Thorax
2008;63:129-34
17. Aurora P, Stanojevic S, Wade A, Oliver C, Kozlowska W, Lum
S et al. Lung clearance index at 4 years predicts subsequent
lung function in children with cystic fibrosis. Am J Respir
Crit Care Med 2011;183:752-8
18. Amin R, Subbarao P, Jabar A, Balkovec S, Jensen R,
Kerrigan S et al. Hypertonic saline improves the LCI in
paediatric patients with CF with normal lung function.
Thorax 2010;65:379-83
19. Amin R, Subbarao P, Lou w, Jabar A, Balkovec S, Jensen R et
al. The effect of dornase alfa on ventilation inhomogeneity
in patients with cystic fibrosis. Eur Respir J 2011;37:806-
12
20. Davies J, Sheridan H, Bell N, Cunningham S, Davis SD,
Elborn JS et al. Assessment of clinical response to ivacaftor
with lung clearance index in cystic fibrosis patients with
a G551D-CFTR mutation and preserved spirometry: a
randomised controlled trial. Lancet Resp Med 2013;1:630-
8
21. Subbarao P, Stanojevic S, Brown M, Jensen R, Rosenfeld M,
Davis S et al. Lung clearance index as an outcome measure
for clinical trials in young children with cystic fibrosis. A
pilot study using inhaled hypertonic saline. Am J Respir Crit
Care Med 2013;188:456-60
22. Sonnappa S, Bastardo C, Wade A, Saglani S, McKenzie S,
Bush A et al. Symptom-pattern henothype and pulmonary
function in preschool wheezers. J Allergy Clin Inmunol
2010;126: 519-26
23. Macleod KA, Horsley AR, Bell NJ, Greening AP, Innes JA,
Cunningham S. Ventilation heterogeneity in children with
well controlled asthma with normal spirometry indicates
residual airways disease. Thorax 2009;64:33-7
24. Downie SR, Salome CM, Verbanck S, Thompson B, Berend
N, King GG. Ventilation heterogeneity is a major determinant
of airway hyperresponsiveness in asthma, independent of
airway inflammation. Thorax 2007;62:684-9
25. Lahzami S, Schoeffel RE, Pechey V, Reid C, Greenwood M,
Salome CM, et al. Small airways function declines after
allogeneic haematopoietic stem cell transplantation. Eur
Respir J 2011;38:1180-8
26. Hülskamp G, Pillow JJ, Dinger J, Stocks J. Lung Function
Tests in Neonates and Infants with Chronic Lung Disease
of Infancy: Functional Residual Capacity. Pediatr Pulmonol
2006;41:1-22.
27. Pillow JJ, Frerichs I, Stocks J. Lung Function Tests in
Neonates and Infants with Chronic Lung Disease: Global
and Regional Ventilation Inhomogeneity. Pediatr Pulmonol
2006;41:105-21
28. Lum S, Kirkby J, Welsh L, Marlow N, Hennessy E, Stocks
J. Nature and severity of lung function abnormalities in
extremely pre-term children at 11 years of age. Eur Respir
J 2011;37:1199-207